
Trigyn Technologies Hits Upper Circuit Amid Strong Buying Pressure
2025-12-04 14:00:08Trigyn Technologies Ltd witnessed a significant surge in its share price on 4 December 2025, hitting the upper circuit limit as robust buying interest dominated trading activity. The stock outperformed its sector peers and broader market indices, reflecting heightened investor enthusiasm despite its micro-cap status.
Read More
Trigyn Techno. Sees Revision in Market Evaluation Amidst Challenging Financial Trends
2025-12-04 11:08:46Trigyn Techno., a microcap player in the Computers - Software & Consulting sector, has experienced a revision in its market evaluation reflecting recent shifts in its fundamental and technical outlook. This adjustment follows a period marked by subdued financial performance and valuation concerns, prompting a reassessment of the company’s standing within its sector.
Read More
Trigyn Technologies Financial Trend Update: Quarterly Performance and Market Returns Analysis
2025-11-19 08:00:41Trigyn Technologies, a player in the Computers - Software & Consulting sector, has exhibited a shift in its financial trend parameter from negative to flat in the quarter ending September 2025. The company reported its highest quarterly net sales at ₹241.95 crores, alongside peak quarterly PAT of ₹5.30 crores and EPS of ₹1.71, signalling a notable change in recent performance compared to prior periods.
Read MoreIs Trigyn Techno. overvalued or undervalued?
2025-11-18 08:23:29As of 17 November 2025, Trigyn Technologies has moved from an expensive to a very expensive valuation grade. The company is currently overvalued, as indicated by its high PE ratio of 47.41, a negative EV to EBIT of -144.39, and a PEG ratio of 0.00. In comparison, peers such as TCS and Infosys have significantly lower PE ratios of 22.32 and 22.23, respectively, highlighting the disparity in valuation. Additionally, Trigyn's financial metrics show concerning trends, including a negative capital employed reflected in its ROCE and a low ROE of 0.64%. The company's recent stock performance has also lagged behind the Sensex, with a year-to-date return of -31.06% compared to the Sensex's 8.72%, further reinforcing the notion that Trigyn is not only overvalued but also struggling in the current market environment....
Read More
Trigyn Technologies Ltd Surges 5% Today, Marking Third Consecutive Day of Gains
2025-11-14 15:25:55Trigyn Technologies Ltd is experiencing notable buying activity, with a recent rise in stock price and consecutive gains over the past three days. Despite this short-term positive trend, the stock has faced challenges over the year, reflecting volatility in the microcap software and consulting sector.
Read More
Trigyn Technologies Stock Hits Upper Circuit Limit with Intraday High of Rs 75.92
2025-11-14 10:00:27Trigyn Technologies Ltd experienced notable trading activity, reaching its upper circuit limit with an intraday high of Rs 75.92. The stock outperformed its sector despite a decline in investor participation and lower delivery volumes. It remains above its five-day moving average but below longer-term averages.
Read MoreHow has been the historical performance of Trigyn Techno.?
2025-11-13 23:39:13Answer: The historical performance of Trigyn Techno. shows a significant decline in net sales and profits over the past few years, particularly from Mar'24 to Mar'25. Breakdown: Trigyn Techno. reported net sales of 894.41 Cr in Mar'25, a notable decrease from 1,279.66 Cr in Mar'24 and 1,272.72 Cr in Mar'23. The total operating income followed a similar trend, dropping to 894.41 Cr in Mar'25 from 1,279.66 Cr in Mar'24. The company's total expenditure also decreased to 875.63 Cr in Mar'25 from 1,244.91 Cr in Mar'24, leading to an operating profit (PBDIT) of 36.52 Cr in Mar'25, down from 46.74 Cr in Mar'24. Profit before tax was reported at 27.56 Cr in Mar'25, compared to 38.21 Cr in Mar'24, while profit after tax fell to 12.94 Cr from 19.96 Cr in the previous year. The consolidated net profit also decreased to 11.77 Cr in Mar'25 from 19.96 Cr in Mar'24. Despite these declines, the company's total assets incr...
Read MoreIs Trigyn Techno. overvalued or undervalued?
2025-11-10 08:11:53As of 7 November 2025, Trigyn Technologies has moved from a fair to an expensive valuation grade. The company is currently considered overvalued based on its significant negative PE ratio of -2396.24, an EV to EBITDA of -27.79, and a Price to Book Value of 0.30. These ratios indicate underlying financial distress and a lack of profitability, which are concerning for potential investors. In comparison to its peers, Trigyn's valuation metrics starkly contrast with TCS, which has a PE ratio of 21.53 and an EV to EBITDA of 8.37, and Infosys, with a PE ratio of 21.82 and an EV to EBITDA of 5.02. The disparity in these ratios highlights Trigyn's unfavorable position within the industry. Furthermore, the company's stock has underperformed significantly against the Sensex, with a year-to-date return of -33.25% compared to the Sensex's 6.50%, reinforcing the notion that Trigyn Technologies is currently overvalued....
Read MoreIs Trigyn Techno. overvalued or undervalued?
2025-11-09 08:10:15As of 7 November 2025, the valuation grade for Trigyn Techno. has moved from fair to expensive, indicating a shift in perception regarding its market value. The company is currently considered overvalued. Key ratios include a PE Ratio of -2396.24, an EV to EBITDA of -27.79, and a Price to Book Value of 0.30, all of which suggest significant financial distress and poor profitability. In comparison to its peers, Trigyn Techno. stands out negatively against companies like TCS, which has a PE Ratio of 21.53 and an EV to EBITDA of 8.37, and Infosys, with a PE Ratio of 21.82 and an EV to EBITDA of 5.02. The stark contrast in these ratios highlights Trigyn's challenges in the software and consulting industry. Additionally, the company's stock has underperformed significantly against the Sensex, with a year-to-date return of -33.25% compared to the Sensex's 6.50%, reinforcing the notion that Trigyn Techno. is curr...
Read MoreAnnouncement under Regulation 30 (LODR)-Change in Management
21-Nov-2025 | Source : BSECessation of Mr. Vikram Chandna as Chief Executive Officer (CEO) w.e.f November 21 2025
Announcement under Regulation 30 (LODR)-Newspaper Publication
15-Nov-2025 | Source : BSEPlease find attached herewith Newspaper Publication
Announcement under Regulation 30 (LODR)-Press Release / Media Release
14-Nov-2025 | Source : BSEPlease find attached herewith Press Release
Corporate Actions
No Upcoming Board Meetings
Trigyn Technologies Ltd has declared 2% dividend, ex-date: 17 Sep 20
No Splits history available
No Bonus history available
No Rights history available






